Back
Monopar Therapeutics Vs. Oklo Industry Stock Comparison
Buy
62
MNPR
Monopar Therapeutics
Last Price:
$25.33
Seasonality Move:
-3.22%
Buy
58
OKLO
Oklo
Last Price:
$29.50
Seasonality Move:
5.58%
Buy
62
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $25.16. The Score for MNPR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $25.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
OKLO Stock Price Chart
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.81 | Buy |
Relative Strength Index (14 RSI): | 55.64 | Buy |
Chaikin Money Flow: | 14202 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.86 - 26.44) | Buy |
Bollinger Bands (100): | (3.63 - 21.89) | Buy |
OKLO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.8 | Buy |
Relative Strength Index (14 RSI): | 67.48 | Buy |
Chaikin Money Flow: | -5066862 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.58 - 24.92) | Buy |
Bollinger Bands (100): | (8.31 - 23.07) | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.71 | Buy |
20-day SMA: | 24.57 | Buy |
50-day SMA: | 20.95 | Buy |
200-day SMA: | 8.11 | Buy |
8-day EMA: | 23.87 | Buy |
20-day EMA: | 23.62 | Buy |
50-day EMA: | 20.28 | Buy |
200-day EMA: | 10.92 | Buy |
OKLO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.04 | Buy |
20-day SMA: | 21.95 | Buy |
50-day SMA: | 22.19 | Buy |
200-day SMA: | 12.98 | Buy |
8-day EMA: | 25.78 | Buy |
20-day EMA: | 23.41 | Buy |
50-day EMA: | 20.92 | Buy |
200-day EMA: | 14.74 | Buy |
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $2.12 per share.
Oklo Earnings Growth & OKLO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.27 per share, and a decrease next year of $0.06 per share.
Monopar Therapeutics Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Oklo Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |